Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients.

Ramachandran, Geetha and Kumar, A K Hemanth and Ponnuraja, C and Ramesh, K and Rajesh, Lakshmi and Chandrasekharan, C and Swaminathan, Soumya (2013) Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients. The Indian journal of medical research, 138 (6). pp. 955-61. ISSN 0971-5916

Archive 201374.pdf - Published Version Download (314kB)

Abstract

BACKGROUND & OBJECTIVES Among patients with HIV-associated tuberculosis (TB), reduced plasma non-nucleoside reverse transcriptase inhibitors (NNRTI) concentrations during rifampicin (RMP) co-administration could lead to HIV treatment failure. This study was undertaken to examine the association between plasma nevirapine (NVP) and efavirenz (EFV) concentrations and virological outcomes in patients infected with HIV-1 and TB. METHODS This was a nested study undertaken in a clinical trial of patients with HIV-1 and TB, randomized to two different once-daily antiretroviral treatment (ART) regimens along with anti-TB treatment (ATT). Trough concentrations of plasma NVP and EFV were estimated at months 1 (during ATT and ART) and 6 months (ART only) by HPLC. Plasma HIV-1 RNA level >400 copies/ml or death within 6 months of ART were considered as unfavourable outcomes. Genotyping of CYP2B6 516G>T polymorphism was performed. RESULTS Twenty nine per cent of patients in NVP arm had an unfavourable outcome at 6 months compared to 9 per cent in EFV arm (P<0.08). The mean NVP and EFV levels estimated at 1 and 6 months did not significantly differ between favourable and unfavourable responders. Logistic regression analysis showed CYP2B6 516G>T polymorphism significantly associated with virologic outcome in patients receiving EFV-based regimen. INTERPRETATION & CONCLUSIONS Trough plasma concentrations of NVP and EFV did not show any association with response to ART in patients on ATT and once-daily ART. CYP2B6 516G>T polymorphism was associated with virologic outcome among patients on EFV.

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	HIV-1 & tuberculosis - NNRTIs - rifampicin - TDM - virologic outcome
Subjects:	Tuberculosis > Laboratory Research > Biochemical Tuberculosis > Laboratory Research > Pharmacological
Divisions:	Basic Science Research > Biochemistry Basic Science Research > Clinical Pharmacology
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	21 Sep 2022 11:19
Last Modified:	21 Sep 2022 11:19
URI:	http://eprints.nirt.res.in/id/eprint/1270

Actions (login required)

View Item